Events Archives - Page 238 of 287

WednesdaySep 20, 2017 10:06 am

The Green Organic Dutchman Rides on Quality Medical Cannabis, Private Placement and Strong Leadership

The Green Organic Dutchman (“TGOD”), a 100-percent owned subsidiary of The Green Organic Dutchman Holdings Ltd., produces high-quality medical marijuana. Its organic medical cannabis is farm grown and pesticide-free. There are many factors in favor of the company. The demand in a legal national market, consumer preference for organic foods and products of all kinds and a recent $20 million private placement are all positive signs. Also, TGOD is among a select group of companies licensed to cultivate medical cannabis by Health Canada under the Access to Cannabis for Medical Purposes Regulations. Those interested in investing should contact TGOD directly…

TuesdaySep 19, 2017 9:00 am

What it Takes to Thrive in Canada’s Multi-Billion-Dollar Marijuana Industry

NetworkNewsWire Editorial Coverage: Canadian medicinal marijuana sales could exceed $8 billion by 2024, as forecast by Canaccord Genuity Group’s November 2016 market research report. ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) (ABcann Profile) is considered one of Canada’s strongest growers, boasting a customer retention rate of 94.7 percent, no history of product recalls, and computer-controlled production that have strengthened the company’s reputation for its pharmaceutical-grade cannabis. While ABcann already occupies a strong position, its leadership team continues to draw on pharmaceutical and capital markets experience to help achieve broader corporate goals. These advantages separate ABcann from other producers such as…

TuesdaySep 19, 2017 9:00 am

Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects

NetworkNewsWire Editorial Coverage: The hazards of pharmacology have hardly changed since Paracelsus, a famous Renaissance physician, astoundingly declared that it was only the dosage that separated a medicine from a poison, bundled with adverse side effects. Despite considerable advances in medicine, many medications are still as injurious as their Renaissance precursors. Nevertheless, recent developments in drug delivery technologies increasingly suggest that safer, more efficient treatment options are on the horizon. At the core of this potential are cannabinoids. Developments in this rapidly growing segment of the medical marijuana market are pioneered by a vast number of innovators, including Lexaria Bioscience…

ThursdaySep 14, 2017 9:00 am

Innovative Cannabis Players Offer Promising Entry into Explosive Market

NetworkNewsWire Editorial Coverage: It is no secret that the legal marijuana market is exploding in North America. Analysts have predicted the cannabis market in the United States could reach $24.1 billion by 2025, and recent polls indicate 61 percent of Americans now believe marijuana use should be federally legalized1. Measures are currently being taken in Canada to legalize recreational marijuana by 2018. On a global scale, the worldwide cannabis market has been projected to reach up to $55.8 billion USD by 20252. A wide variety of players have been scrambling to stake a claim in this booming market, whether through…

ThursdaySep 14, 2017 9:00 am

Industry Leaders Find Success in Subscription-Based Business

NetworkNewsWire Editorial Coverage: Thanks to subscription-based business models, consumers are not left to wonder what the best buying decisions may be. Companies that offer subscriptions can provide customers with a multitude of services bundled together, whether the product is streaming television programs, design or sales software, or purchasing and managing lottery tickets. On the corporate side, subscription services have enabled companies to be more flexible and scalable toward their offerings while providing them with greater, more predictable revenue. LottoGopher Holdings (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) (LottoGopher Profile) is one example of a company that has succeeded with its subscription…

WednesdaySep 13, 2017 9:00 am

Biosynthesis Technology Could Transform Cannabinoid Production

NetworkNewsWire Editorial Coverage: The upward trajectory of the cannabis industry has garnered comparisons to the Internet boom of the early 2000s, as North American sales are on pace to record a compound annual growth rate of 25 percent through 2021, according to Arcview Market Research (1). These comparisons are certainly attention-grabbing, but the full potential of the evolving marijuana market could be even larger. InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) (IMLFF Profile), a Vancouver-based biopharmaceutical company, has developed a robust, high-yield biosynthesis process capable of enabling the manufacture of all 90+ naturally-occurring cannabinoids found in the cannabis plant. This…

WednesdaySep 13, 2017 9:00 am

Cannabis Sector Strategies Light the Way for Industry Growth

NetworkNewsWire Editorial Coverage: A new report out from Hexa Research projects that the domestic market for medical marijuana is slated to grow over 250 percent by 2024 to reach a new worth of nearly $20 billion (1). Globally, the market is estimated as reaching some $55.8 billion by 2025. Players in the space are banking on this incredible growth, executing their individual strategies to take part in the vast opportunities. SinglePoint, Inc. (SING) (SING Profile) employs a diversified acquisition-based strategy and is moving toward select joint-ventures to further enhance revenue growth potential as an increasingly cannabis-focused holding company. The goal…

TuesdaySep 12, 2017 2:18 pm

ORHub’s (ORHB) Revolutionary Software Solution Could Help Pave the Way to Value-Based Healthcare in the US

ORHub is a pioneering cloud-based healthcare solution that can help medical providers eliminate inefficiencies, cut costs and improve quality of care ORHub has created a new category of healthcare IT vertical-specific software called surgical resource management (SRM) ORHub creates the largest source of intelligent surgical information in the world, opening up a vast pipeline of revenue opportunities ORHub is positioned to become the universal SRM platform for improving healthcare efficiency and cutting costs “Value-based healthcare” is a buzz phrase these days, and surgical procedures are at the center of the issue, with hospitals spending, on average, between 48 and 50…

TuesdaySep 12, 2017 9:00 am

Alzheimer’s Disease: Cannabis Formulation Shows Promise

NetworkNewsWire Editorial Coverage: Known as America’s most expensive disease, with an estimated cost to the U.S. economy of $236 billion in 2016, Alzheimer’s disease (AD) affects more than 5.3 million Americans. Over the next 20 years, the number of those afflicted with the disease is expected to double. The forecast is staggering, considering that no effective cure has been found, but the quest for one continues, with India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), Anavex Life Sciences (NASDAQ: AVXL), Axovant Sciences (NYSE: AXON), AC Immune Ltd. (NASDAQ: ACIU) and Biogen, Inc. (NASDAQ: BIIB) all exploring a variety of approaches…

TuesdaySep 12, 2017 9:00 am

Cannabis Biotechs Taking Leading Stance in Global Marijuana Market

With leading recent estimates clocking the 2016 North American legal cannabis market between $6.7 and $7.2 billion, the only thing more impressive about the industry is the growth projections. Research estimates a whopping compound annual sales growth rate of 25 percent through 2021. This stupendous growth, driven by more and more states adopting medical and even recreational legislation, has combined with the fact that the FDA has not yet approved any drug product containing or derived from botanical marijuana to create a perfect storm for cannabis biotechs like Vancouver-based InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) (IMLFF Profile) and GW…